{"issuance_frequency":"","notes_translated":{"fr":"L'infection à C. trachomatis est l'infection transmissible sexuellement la plus fréquemment déclarée au Canada. Si elle n'est pas traitée, l'infection à Chlamydia peut se propager du site local d'inoculation et entraîner de complications graves et(ou) des séquelles telles que l'atteinte inflammatoire pelvienne (AIP), grossesse ectopique, infertilité, douleur pelvienne chronique, orchiépididymite et le syndrome de Reiter.","en":"C. trachomatis is the most common reportable sexually transmitted infection in Canada. If not treated, C. trachomatis can spread from a local site of inoculation and lead to serious complications and/or sequelae, such as pelvic inflammatory disease (PID), ectopic pregnancy, infertility, chronic pelvic pain, epididymo-orchitis and Reiter syndrome."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"unknown","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"70d52c46-01e9-47cc-9a36-ecfb518b103e","metadata_created":"2020-06-17T17:01:04.989016","subject":["health_and_safety"],"date_modified":"2020-05-21 00:00:00","pspc_identification_number":"","metadata_modified":"2020-06-17T17:01:04.989026","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2020-06-17","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Chlamydia","LGV","dépistage","traitement","transmission","facteurs de risque","relations sexuelles","ITSS"],"en":["Chlamydia","LGV","screening","treatment","transmission","risk factors","sex","STBBI"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"Chlamydia et LGV","en":"Chlamydia and LGV"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"70d52c46-01e9-47cc-9a36-ecfb518b103e","datastore_active":false,"id":"bd7c1511-c1d9-4443-ae72-04bdf7686769","character_set":"","state":"active","name_translated":{"fr":"Informations importantes et ressources","en":"Key information and resources"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Key information and resources","language":["en"],"created":"2020-06-17T17:01:05.393914","url":"https://www.canada.ca/en/public-health/services/infectious-diseases/sexual-health-sexually-transmitted-infections/canadian-guidelines/chlamydia-lgv.html","last_modified":null,"position":0,"revision_id":"baeb361a-c2c1-4763-96d2-db592bfbc081","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"70d52c46-01e9-47cc-9a36-ecfb518b103e","datastore_active":false,"id":"db6fc01a-d867-487a-a32a-d039cb171fa4","character_set":"","state":"active","name_translated":{"fr":"Informations importantes et ressources","en":"Key information and resources"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Key information and resources","language":["fr"],"created":"2020-06-17T17:01:05.393923","url":"https://www.canada.ca/fr/sante-publique/services/maladies-infectieuses/sante-sexuelle-infections-transmissibles-sexuellement/lignes-directrices-canadiennes/chlamydia-lgv.html","last_modified":null,"position":1,"revision_id":"baeb361a-c2c1-4763-96d2-db592bfbc081","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"70d52c46-01e9-47cc-9a36-ecfb518b103e","datastore_active":false,"id":"f6a8c311-5d8e-4801-939e-9c40f4d8596d","character_set":"","state":"active","name_translated":{"fr":"Facteurs de risque et manifestations cliniques","en":"Risk factors and clinical manifestation"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Risk factors and clinical manifestation","language":["en"],"created":"2020-06-17T17:01:05.393926","url":"https://www.canada.ca/en/public-health/services/infectious-diseases/sexual-health-sexually-transmitted-infections/canadian-guidelines/chlamydia-lgv/risk-factors-clinical-manifestation.html","last_modified":null,"position":2,"revision_id":"baeb361a-c2c1-4763-96d2-db592bfbc081","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"70d52c46-01e9-47cc-9a36-ecfb518b103e","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ba1d0995-0c66-49f2-a8ea-1e783aae16f5","related_relationship":"","name_translated":{"fr":"Facteurs de risque et manifestations cliniques","en":"Risk factors and clinical manifestation"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Risk factors and clinical manifestation","language":["fr"],"created":"2020-06-17T17:01:05.393929","url":"https://www.canada.ca/fr/sante-publique/services/maladies-infectieuses/sante-sexuelle-infections-transmissibles-sexuellement/lignes-directrices-canadiennes/chlamydia-lgv/depistage-test-diagnostiques.html","last_modified":null,"position":3,"revision_id":"baeb361a-c2c1-4763-96d2-db592bfbc081","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"70d52c46-01e9-47cc-9a36-ecfb518b103e","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d338aec7-c29f-4d29-9f02-901fb3b4394f","related_relationship":"","name_translated":{"fr":"Dépistage et test diagnostiques","en":"Screening and diagnostic testing"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Screening and diagnostic testing","language":["en"],"created":"2020-06-17T17:01:05.393932","url":"https://www.canada.ca/en/public-health/services/infectious-diseases/sexual-health-sexually-transmitted-infections/canadian-guidelines/chlamydia-lgv/screening-diagnostic-testing.html","last_modified":null,"position":4,"revision_id":"baeb361a-c2c1-4763-96d2-db592bfbc081","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"70d52c46-01e9-47cc-9a36-ecfb518b103e","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"516c718a-acb5-40d9-a8b0-0bc83a380f50","related_relationship":"","name_translated":{"fr":"Dépistage et test diagnostiques","en":"Screening and diagnostic testing"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Screening and diagnostic testing","language":["fr"],"created":"2020-06-17T17:01:05.393934","url":"https://www.canada.ca/fr/sante-publique/services/maladies-infectieuses/sante-sexuelle-infections-transmissibles-sexuellement/lignes-directrices-canadiennes/chlamydia-lgv/depistage-test-diagnostiques.html","last_modified":null,"position":5,"revision_id":"baeb361a-c2c1-4763-96d2-db592bfbc081","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"70d52c46-01e9-47cc-9a36-ecfb518b103e","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"9dc57d8f-591e-4172-a3d0-18ef860cc71c","related_relationship":"","name_translated":{"fr":"Traitement et suivi","en":"Treatment and follow-up"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Treatment and follow-up","language":["en"],"created":"2020-06-17T17:01:05.393937","url":"https://www.canada.ca/en/public-health/services/infectious-diseases/sexual-health-sexually-transmitted-infections/canadian-guidelines/chlamydia-lgv/treatment-follow-up.html","last_modified":null,"position":6,"revision_id":"baeb361a-c2c1-4763-96d2-db592bfbc081","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"70d52c46-01e9-47cc-9a36-ecfb518b103e","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"991630e6-2f31-4720-a85e-90fd1ed6c358","related_relationship":"","name_translated":{"fr":"Traitement et suivi","en":"Treatment and follow-up"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Treatment and follow-up","language":["fr"],"created":"2020-06-17T17:01:05.393940","url":"https://www.canada.ca/fr/sante-publique/services/maladies-infectieuses/sante-sexuelle-infections-transmissibles-sexuellement/lignes-directrices-canadiennes/chlamydia-lgv/traitement-suivi.html","last_modified":null,"position":7,"revision_id":"baeb361a-c2c1-4763-96d2-db592bfbc081","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"70d52c46-01e9-47cc-9a36-ecfb518b103e","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"1ddf494e-02b8-4488-a730-716a54bb4d75","related_relationship":"","name_translated":{"fr":"Prévention et contrôle","en":"Prevention and control"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Prevention and control","language":["en"],"created":"2020-06-17T17:01:05.393942","url":"https://www.canada.ca/en/public-health/services/infectious-diseases/sexual-health-sexually-transmitted-infections/canadian-guidelines/chlamydia-lgv/prevention-control.html","last_modified":null,"position":8,"revision_id":"baeb361a-c2c1-4763-96d2-db592bfbc081","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"70d52c46-01e9-47cc-9a36-ecfb518b103e","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b3af9090-583a-4610-bd58-fdee346b2c5b","related_relationship":"","name_translated":{"fr":"Prévention et contrôle","en":"Prevention and control"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Prevention and control","language":["fr"],"created":"2020-06-17T17:01:05.393944","url":"https://www.canada.ca/fr/sante-publique/services/maladies-infectieuses/sante-sexuelle-infections-transmissibles-sexuellement/lignes-directrices-canadiennes/chlamydia-lgv/prevention-controle.html","last_modified":null,"position":9,"revision_id":"baeb361a-c2c1-4763-96d2-db592bfbc081","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"70d52c46-01e9-47cc-9a36-ecfb518b103e","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"c4901dde-9941-4624-a882-8036979a22ff","related_relationship":"","name_translated":{"fr":"Étiologie et épidémiologie","en":"Etiology and epidemiology "},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Etiology and epidemiology ","language":["en"],"created":"2020-06-17T17:01:05.393947","url":"https://www.canada.ca/en/public-health/services/infectious-diseases/sexual-health-sexually-transmitted-infections/canadian-guidelines/chlamydia-lgv/etiology-epidemiology.html","last_modified":null,"position":10,"revision_id":"baeb361a-c2c1-4763-96d2-db592bfbc081","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"70d52c46-01e9-47cc-9a36-ecfb518b103e","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"eead206d-7c7c-479d-b730-8842185c54b4","related_relationship":"","name_translated":{"fr":"Étiologie et épidémiologie","en":"Etiology and epidemiology "},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Etiology and epidemiology ","language":["fr"],"created":"2020-06-17T17:01:05.393949","url":"https://www.canada.ca/fr/sante-publique/services/maladies-infectieuses/sante-sexuelle-infections-transmissibles-sexuellement/lignes-directrices-canadiennes/chlamydia-lgv/etiologie-epidemiologie.html","last_modified":null,"position":11,"revision_id":"baeb361a-c2c1-4763-96d2-db592bfbc081","resource_type":"website"}],"place_of_publication":[],"num_resources":12,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2020-05-21 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"70d52c46-01e9-47cc-9a36-ecfb518b103e","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"C. trachomatis is the most common reportable sexually transmitted infection in Canada. If not treated, C. trachomatis can spread from a local site of inoculation and lead to serious complications and/or sequelae, such as pelvic inflammatory disease (PID), ectopic pregnancy, infertility, chronic pelvic pain, epididymo-orchitis and Reiter syndrome.","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Chlamydia and LGV","revision_id":"baeb361a-c2c1-4763-96d2-db592bfbc081"}